123 related articles for article (PubMed ID: 27742266)
41. Evaluation of heparin cofactor II-thrombin complex as a biomarker on blood spots from mucopolysaccharidosis I, IIIA and IIIB mice.
Langford-Smith K; Arasaradnam M; Wraith JE; Wynn R; Bigger BW
Mol Genet Metab; 2010 Mar; 99(3):269-74. PubMed ID: 19926322
[TBL] [Abstract][Full Text] [Related]
42. Recombinant encapsulated cells overexpressing alpha-L-iduronidase correct enzyme deficiency in human mucopolysaccharidosis type I cells.
Baldo G; Quoos Mayer F; Burin M; Carrillo-Farga J; Matte U; Giugliani R
Cells Tissues Organs; 2012; 195(4):323-9. PubMed ID: 21778683
[TBL] [Abstract][Full Text] [Related]
43. Identification and molecular characterization of alpha-L-iduronidase mutations present in mucopolysaccharidosis type I patients undergoing enzyme replacement therapy.
Yogalingam G; Guo XH; Muller VJ; Brooks DA; Clements PR; Kakkis ED; Hopwood JJ
Hum Mutat; 2004 Sep; 24(3):199-207. PubMed ID: 15300847
[TBL] [Abstract][Full Text] [Related]
44. Improvements in mucopolysaccharidosis I mice after adult retroviral vector-mediated gene therapy with immunomodulation.
Ma X; Liu Y; Tittiger M; Hennig A; Kovacs A; Popelka S; Wang B; Herati R; Bigg M; Ponder KP
Mol Ther; 2007 May; 15(5):889-902. PubMed ID: 17311010
[TBL] [Abstract][Full Text] [Related]
45. Impaired bone remodeling and its correction by combination therapy in a mouse model of mucopolysaccharidosis-I.
Kuehn SC; Koehne T; Cornils K; Markmann S; Riedel C; Pestka JM; Schweizer M; Baldauf C; Yorgan TA; Krause M; Keller J; Neven M; Breyer S; Stuecker R; Muschol N; Busse B; Braulke T; Fehse B; Amling M; Schinke T
Hum Mol Genet; 2015 Dec; 24(24):7075-86. PubMed ID: 26427607
[TBL] [Abstract][Full Text] [Related]
46. Glycosaminoglycan degradation fragments in mucopolysaccharidosis I.
Fuller M; Meikle PJ; Hopwood JJ
Glycobiology; 2004 May; 14(5):443-50. PubMed ID: 14718373
[TBL] [Abstract][Full Text] [Related]
47. Proteomic analysis of propiconazole responses in mouse liver: comparison of genomic and proteomic profiles.
Ortiz PA; Bruno ME; Moore T; Nesnow S; Winnik W; Ge Y
J Proteome Res; 2010 Mar; 9(3):1268-78. PubMed ID: 20095644
[TBL] [Abstract][Full Text] [Related]
48. Prevention of neuropathology in the mouse model of Hurler syndrome.
Desmaris N; Verot L; Puech JP; Caillaud C; Vanier MT; Heard JM
Ann Neurol; 2004 Jul; 56(1):68-76. PubMed ID: 15236403
[TBL] [Abstract][Full Text] [Related]
49. Comparative two-dimensional polyacrylamide gel electrophoresis (2D-PAGE) of human milk to identify dysregulated proteins in breast cancer.
Aslebagh R; Channaveerappa D; Arcaro KF; Darie CC
Electrophoresis; 2018 May; ():. PubMed ID: 29756217
[TBL] [Abstract][Full Text] [Related]
50. Immune-Mediated Inflammation May Contribute to the Pathogenesis of Cardiovascular Disease in Mucopolysaccharidosis Type I.
Khalid O; Vera MU; Gordts PL; Ellinwood NM; Schwartz PH; Dickson PI; Esko JD; Wang RY
PLoS One; 2016; 11(3):e0150850. PubMed ID: 26986213
[TBL] [Abstract][Full Text] [Related]
51. Co-Analysis of Serum and Urine Differentially Expressed Proteins in Mucopolysaccharidosis Type I.
Liu K; Wan G; Li Y; Liang Z; Meng Y; Yuan X; Duan J
J Proteome Res; 2024 Feb; 23(2):718-727. PubMed ID: 38164767
[TBL] [Abstract][Full Text] [Related]
52. Altered Cellular Homeostasis in Murine MPS I Fibroblasts: Evidence of Cell-Specific Physiopathology.
Viana GM; do Nascimento CC; Paredes-Gamero EJ; D'Almeida V
JIMD Rep; 2017; 36():109-116. PubMed ID: 28220405
[TBL] [Abstract][Full Text] [Related]
53. Surrogate Cerebrospinal Fluid Biomarkers for Assessing the Efficacy of Gene Therapy in Hurler Syndrome.
Haseloff RF; Trudel S; Birke R; Schümann M; Krause E; Gomila C; Heard JM; Blasig IE; Ausseil J
Front Neurol; 2021; 12():640547. PubMed ID: 34054689
[TBL] [Abstract][Full Text] [Related]
54. Actin Cytoskeleton Polymerization and Focal Adhesion as Important Factors in the Pathomechanism and Potential Targets of Mucopolysaccharidosis Treatment.
Gaffke L; Rintz E; Pierzynowska K; Węgrzyn G
Cells; 2023 Jul; 12(13):. PubMed ID: 37443816
[TBL] [Abstract][Full Text] [Related]
55. Comparative proteomic profiling reveals aberrant cell proliferation in the brain of embryonic Ts1Cje, a mouse model of Down syndrome.
Ishihara K; Kanai S; Sago H; Yamakawa K; Akiba S
Neuroscience; 2014 Dec; 281():1-15. PubMed ID: 25261685
[TBL] [Abstract][Full Text] [Related]
56. Proteomic analysis of an immortalized mouse pancreatic stellate cell line identifies differentially-expressed proteins in activated vs nonproliferating cell states.
Paulo JA; Urrutia R; Banks PA; Conwell DL; Steen H
J Proteome Res; 2011 Oct; 10(10):4835-44. PubMed ID: 21838295
[TBL] [Abstract][Full Text] [Related]
57. [Differential proteins revealed with proteomics in the brain tissue of Paralichthys olivaceus under the stress of methyl parathion].
Na H; Huang Q; Chen Y; Huang H
Se Pu; 2008 Nov; 26(6):662-6. PubMed ID: 19253540
[TBL] [Abstract][Full Text] [Related]
58. Quantitative proteomic analysis of murine white adipose tissue for peritoneal cancer metastasis.
Feist PE; Loughran EA; Stack MS; Hummon AB
Anal Bioanal Chem; 2018 Feb; 410(5):1583-1594. PubMed ID: 29282499
[TBL] [Abstract][Full Text] [Related]
59. Mucopolysaccharidosis type I: current knowledge on its pathophysiological mechanisms.
Campos D; Monaga M
Metab Brain Dis; 2012 Jun; 27(2):121-9. PubMed ID: 22527994
[TBL] [Abstract][Full Text] [Related]
60. Mass Spectrometry-Based Proteomics of Human Milk to Identify Differentially Expressed Proteins in Women with Breast Cancer versus Controls.
Aslebagh R; Whitham D; Channaveerappa D; Mutsengi P; Pentecost BT; Arcaro KF; Darie CC
Proteomes; 2022 Oct; 10(4):. PubMed ID: 36412635
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
